Marshall Wace
FHLT

Marshall Wace’s Future Health ESG Corp. Common stock FHLT Stock Holding History

Marshall Wace’s Portfolio FHLT Stock Details FHLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-863,753
Closed -$8.65M – 3563
2022
Q3 		$8.65M Hold
863,753
– – 0.02% 986
2022
Q2 		$8.54M Hold
863,753
– – 0.02% 969
2022
Q1 		$8.52M Hold
863,753
– – 0.02% 986
2021
Q4 		$8.42M Buy
+863,753
New +$8.46M 0.02% 997

Other funds holding FHLT

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace's FHLT Position: Q4 2022 in Review

Marshall Wace sold out of Future Health ESG Corp. Common stock (FHLT) in Q4 2022, closing a stake of 863,753 shares — an estimated $8.65M sold.

Marshall Wace first reported a position in FHLT in Q4 2021 and held it in 4 quarters. The position peaked at $8.65M in Q3 2022. 10 funds tracked by Wall St. Rank hold FHLT as of Q4 2022.

  • Marshall Wace reported no remaining Future Health ESG Corp. Common stock position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 863,753 Future Health ESG Corp. Common stock shares in Q4 2022, an estimated $8.65M.
  • Marshall Wace first reported a position in Future Health ESG Corp. Common stock in Q4 2021 and held it in 4 quarters.
  • Marshall Wace's Future Health ESG Corp. Common stock position peaked at $8.65M in Q3 2022.
  • 10 funds tracked by Wall St. Rank held Future Health ESG Corp. Common stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.